This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Evaluation of Ventyx Biosciences' VTX3232 in Participants with Obesity and Cardiovascular Disease

Ticker(s): VTYX, LLY

Who's the expert?

Institution: Indiana University School of Medicine

  • Associate Professor of Medicine and interventional cardiologist; Serves as Director of the Cardiac Catheterization Laboratory at IU West and Director of Peripheral Vascular Interventions for IU Cardiology

  • Manages 1-5 patients with FCS annually

  • Leads research on advanced endovascular techniques and atherosclerosis treatments, advancing minimally invasive therapies for vascular diseases. specializing in coronary, peripheral arterial, and venous disease management through percutaneous procedures.

Interview Goal
This conversation will focus on the landscape of Obesity and Cardiovascular disease along with the potential of Ventyx Biosciences VTX3232

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.